These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35338959)

  • 1. Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis.
    Nie X; Zheng M; Gao L; Hu Y; Zhuang Y; Li X; Zhu L; Liu J; Lin B
    Int Immunopharmacol; 2022 Jun; 107():108726. PubMed ID: 35338959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer.
    Nie X; Gao L; Zheng M; Wang S; Wang C; Li X; Liu O; Gou R; Liu J; Lin B
    BMC Cancer; 2024 Mar; 24(1):330. PubMed ID: 38468232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells.
    Nie X; Gao L; Zheng M; Wang C; Wang S; Li X; Qi Y; Zhu L; Liu J; Lin B
    J Cancer; 2021; 12(19):5772-5788. PubMed ID: 34475991
    [No Abstract]   [Full Text] [Related]  

  • 4. TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer.
    Nie X; Liu C; Guo Q; Zheng MJ; Gao LL; Li X; Liu DW; Zhu LC; Liu JJ; Lin B
    Cancer Manag Res; 2019; 11():839-855. PubMed ID: 30697076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription.
    Tian J; Yang L; Wang Z; Yan H
    Aging (Albany NY); 2022 Jun; 14(13):5390-5405. PubMed ID: 35771155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway.
    Cai Y; Hu Y; Yu F; Tong W; Wang S; Sheng S; Zhu J
    Aging (Albany NY); 2021 Oct; 13(20):23579-23587. PubMed ID: 34689136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHNAK: the giant jack of all trades.
    Davis TA; Loos B; Engelbrecht AM
    Cell Signal; 2014 Dec; 26(12):2683-93. PubMed ID: 25172424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AHNAK, regulated by the OSM/OSMR signaling, involved in the development of primary localized cutaneous amyloidosis.
    Liu H; Qiu B; Yang H; Zheng W; Luo Y; Zhong Y; Lu P; Chen J; Luo Y; Liu J; Yang B
    J Dermatol Sci; 2023 May; 110(2):53-60. PubMed ID: 37100691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
    Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
    Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK.
    Davis T; van Niekerk G; Peres J; Prince S; Loos B; Engelbrecht AM
    Biochem Pharmacol; 2018 Feb; 148():174-183. PubMed ID: 29309757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV-related liver diseases.
    Sun L; Li K; Liu G; Xu Y; Zhang A; Lin D; Zhang H; Zhao X; Jin B; Li N; Zhang Y
    Cancer Med; 2018 Oct; 7(10):5178-5186. PubMed ID: 30259695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SORBS1 serves a metastatic role via suppression of AHNAK in colorectal cancer cell lines.
    Cho WC; Jang JE; Kim KH; Yoo BC; Ku JL
    Int J Oncol; 2020 May; 56(5):1140-1151. PubMed ID: 32319594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R.
    Li K; Song K; Hou Y; Tian Y; Wang H; Sun L; Li A; Zhang Y
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma.
    Dumitru CA; Bankfalvi A; Gu X; Zeidler R; Brandau S; Lang S
    PLoS One; 2013; 8(2):e56420. PubMed ID: 23409183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butorphanol Inhibits the Malignant Biological Behaviors of Ovarian Cancer Cells via Down-Regulating the Expression of TMEFF1.
    Wang B; Li Y; Shen Y; Xu Y; Zhang C
    Onco Targets Ther; 2020; 13():10973-10981. PubMed ID: 33149612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEFF1 and brain tumors.
    Gery S; Yin D; Xie D; Black KL; Koeffler HP
    Oncogene; 2003 May; 22(18):2723-7. PubMed ID: 12743596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
    Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
    Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK.
    Xiang X; Langlois S; St-Pierre ME; Blinder A; Charron P; Graber TE; Fowler SL; Baird SD; Bennett SAL; Alain T; Cowan KN
    Oncogene; 2021 Mar; 40(10):1868-1883. PubMed ID: 33564071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.